JANL
Janel Corporation, through its subsidiaries, provides logistics services worldwide. It operates in three segments: Logistics, Manufacturing, and Life Sciences. The Logistics segment provides cargo transportation logistics management services, including freight forwarding by air, ocean, and land-based carriers; customs brokerage services; warehousing and distribution services; and other value added logistic services, as well as customs entry filing, cargo insurance procurement, logistics planning, product repackaging, and online shipment tracking services. The Manufacturing segment manufactures and distributes mixing equipment and apparatus for various industries, such as chemicals, inks, paints, construction, plastics, adhesives, cosmetics, food, and pharmaceuticals. The Life Sciences segment manufactures and distributes monoclonal and polyclonal antibodies, diagnostic reagents, and other immuno-reagents for biomedical research; provides antibody manufacturing for academic and industry research scientists; and produces products for other life science companies on an original equipment manufacturer basis. The company was formerly known as Janel World Trade Ltd. and changed its name to Janel Corporation in April 2015. Janel Corporation was founded in 1974 and is headquartered in New York, New York.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | 0.51 | $57M | $5M |
| 2025 Q1 | 0.27 | $56M | -$15M |
| 2025 Q4 | 2.16 | $56M | $25M |
| 2025 Q3 | 0.68 | $49M | $11M |
| 2025 Q2 | 1.12 | $51M | $5M |
| 2024 Q1 | 0.28 | $51M | $2M |
| 2024 Q4 | -0.05 | $53M | $133,000 |
| 2024 Q3 | -0.23 | $47M | $2M |